Separation Systems for Commercial Biotechnology Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Separation Systems for Commercial Biotechnology Market is segmented by Method Type (Modern Methods, Conventional Methods) Application, and by Geography.

Separation Systems for Commercial Biotechnology Market Snapshot

Separation Systems for Commercial Biotechnology Market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4.7 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The separation systems for the commercial biotechnology market studied were projected to grow with a CAGR of 4.7% over the forecast period. The major factor attributing to the growth of the market is the increasing advancement of cell separations and increasing demand for biopharmaceuticals. Opportunities in biopharmaceuticals have been increasing over the past decade, as a result of great effectiveness and the safety of these drugs. Biopharmaceuticals have also reduced the number of deaths caused due to cancer and HIV/AIDS in the past decade, which has led to an increase in the adoption of biopharmaceuticals in the global market. Pulmozyme, a recombinant enzyme, is used to treat patients of cystic fibrosis with free DNA in their lungs. Earlier, there was no treatment other than manually pounding the patient’s chest. However, with the help of Pulmozyme, the patient was allowed to dislodge the free DNA from the lungs, which is more effective and safe. Furthermore, increasing government and private funding of the biotechnology segment is further boosting the market growth. However, the high cost of the research and development and patent rights over the MACS technique constraints the market growth.

Scope of the Report

As per the scope of the report, Separation Systems are used for the purification and separation of biological products such as biopharmaceuticals, biochemicals and diagnostic reagents depending upon the electrostatic charge, density, diffusivity, shape, polarity, solubility, and volatility characteristics. The equipment used for the separation of biological material from complex mixture or solution includes chromatography, membrane or filters, and centrifuges. This report is segmented by Method Type, Application, and Geography.

By Methods
Mordern Methods
Microarray
Lab-on-a-chip
Magnetic separation
Others
Conventional Methods
Chromatography
Flow cytometry
Membrane filtration
Others
By Application
Biopharmaceutical
Food & Cosmetics
Agriculture
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Biopharmaceutical Segment is Dominating the Separation Systems for Commercial Biotechnology Market.

Increasing demand for personalized medicines and cell-based therapies coupled with a recent global shortage of vaccines are placing new demands on the segment, thus increasing the adoption of new technology-based systems for large-scale downstream bioprocessing. Pharmaceutical companies that have strong biopharmaceutical pipeline, is rendering the growth of these instruments for purification of biomolecules from debris during its large production. According to the report Biopharmaceutical benchmarks 2018, from 2014 – 2017, 155 biopharmaceutical products have been approved in the United States and/or European Union and globally, 2017 sales generated cumulatively by all biosimilar reference products reached USD 73.3 billion. Furthermore, the increasing funding by the government and major players on the research and development is propelling the segment growth.

Separation Systems for Commercial Biotechnology Market

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to factors such as the presence of key players, established healthcare infrastructure are some of the key factors accountable for its large share in the market. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase the market growth. In this region, the United States has the maximum share due to supportive funding policies, and a developed healthcare market.

Separation Systems for Commercial Biotechnology Market - Growth Rate by Region

Competitive Landscape

The Separation Systems for Commercial Biotechnology market is moderately competitive and consists of several major players. Currently, major players are founding strategic partnerships with other entities and collaborating to enhance their product portfolios in the field of separation systems to develop technologically advanced systems. Some of the companies which are currently dominating the market are Perkin Elmer, Inc., Sartorius AG, Thermo Fisher Scientific, Inc., Merck KGaA, Becton, Dickinson and Company, Shimadzu Corporation, bioMérieux SA, Agilent Technologies, Bio-Rad Laboratories, Inc.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Advances in Cell Separation Techniques and Rising Demand for Biopharmaceuticals

      2. 4.2.2 Rise in Government and Private Funding

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost Involved in R&D

      2. 4.3.2 Patent rights over MACS technique

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Methods

      1. 5.1.1 Mordern Methods

        1. 5.1.1.1 Microarray

        2. 5.1.1.2 Lab-on-a-chip

        3. 5.1.1.3 Magnetic separation

        4. 5.1.1.4 Others

      2. 5.1.2 Conventional Methods

        1. 5.1.2.1 Chromatography

        2. 5.1.2.2 Flow cytometry

        3. 5.1.2.3 Membrane filtration

        4. 5.1.2.4 Others

    2. 5.2 By Application

      1. 5.2.1 Biopharmaceutical

      2. 5.2.2 Food & Cosmetics

      3. 5.2.3 Agriculture

      4. 5.2.4 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Perkin Elmer, Inc.

      2. 6.1.2 Sartorius AG

      3. 6.1.3 Thermo Fisher Scientific, Inc.

      4. 6.1.4 Merck KGaA

      5. 6.1.5 Becton, Dickinson and Company

      6. 6.1.6 Shimadzu Corporation

      7. 6.1.7 bioMerieux SA

      8. 6.1.8 Agilent Technologies

      9. 6.1.9 Bio-Rad Laboratories, Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Separation Systems for Commercial Biotechnology Market market is studied from 2018 - 2026.

The Separation Systems for Commercial Biotechnology Market is growing at a CAGR of 4.7% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Perkin Elmer, Inc., Sartorius AG, Thermo Fisher Scientific, Inc., Merck KGaA, Becton, Dickinson and Company are the major companies operating in Separation Systems for Commercial Biotechnology Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!